Northern Trust Corp Lowers Holdings in Option Care Health, Inc. $OPCH

Key Points

• Northern Trust Corp has reduced its stake in Option Care Health, Inc. by 5.4%, now owning 1.52% of the company valued at approximately $86.87 million.
• Recent quarterly results posted an earnings per share (EPS) of $0.41, surpassing expectations, while revenue increased 15.4% year-over-year to $1.42 billion.
• Institutional investors hold a significant 98.05% of Option Care Health’s stock, with several hedge funds making substantial new acquisitions during the last quarter.

Northern Trust Corp decreased its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 5.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,485,401 shares of the company's stock after selling 141,077 shares during the quarter. Northern Trust Corp owned approximately 1.52% of Option Care Health worth $86,865,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of OPCH. Brooklyn Investment Group raised its stake in Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares during the period. Public Employees Retirement System of Ohio grew its holdings in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in Option Care Health during the 4th quarter valued at approximately $47,000. Bessemer Group Inc. grew its holdings in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after buying an additional 599 shares in the last quarter. Finally, Wealthquest Corp purchased a new position in Option Care Health during the 1st quarter valued at approximately $66,000. Institutional investors own 98.05% of the company's stock.

Insiders Place Their Bets

In other news, Director Timothy P. Sullivan bought 20,000 shares of the stock in a transaction on Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the acquisition, the director owned 49,229 shares of the company's stock, valued at $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was purchased at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the acquisition, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is owned by insiders.

Analysts Set New Price Targets

OPCH has been the subject of several research analyst reports. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities raised their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Finally, Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Trading Down 0.9%

Shares of Option Care Health stock traded down $0.27 on Friday, reaching $28.48. The company had a trading volume of 699,457 shares, compared to its average volume of 1,853,894. The firm's 50-day moving average price is $29.66 and its two-hundred day moving average price is $31.67. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market cap of $4.62 billion, a price-to-earnings ratio of 22.77, a P/E/G ratio of 1.74 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter in the previous year, the business earned $0.30 EPS. Option Care Health's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.